Dr. Joseph C. Maroon Joins Lionheart Health Advisory Board to Advance Bioelectric Brain Health Therapies

March 5th, 2026 7:45 PM
By: Newsworthy Staff

Neurosurgeon Dr. Joseph C. Maroon has joined Lionheart Health's advisory board, bringing decades of expertise in brain health and longevity science to advance the company's bioelectric stimulation technologies aimed at improving cognition, reducing inflammation, and extending healthspan.

Dr. Joseph C. Maroon Joins Lionheart Health Advisory Board to Advance Bioelectric Brain Health Therapies

Lionheart Health, Inc., a leader in bioelectric regenerative medicine and healthspan optimization technologies, announced that Joseph C. Maroon, MD, FACS, has joined its Scientific and Clinical Advisory Board. Dr. Maroon is a board-certified neurosurgeon and internationally recognized authority in brain health, sports neurosurgery, concussion management, neuroinflammation, and longevity science. He serves as Clinical Professor of Neurosurgery at the University of Pittsburgh Medical Center (UPMC) and has been Team Neurosurgeon for the Pittsburgh Steelers for decades.

Dr. Maroon's appointment reinforces Lionheart Health's commitment to advancing evidence-based bioelectric stimulation therapies designed to improve cognition, memory, and mood while supporting neuroplasticity and reducing systemic and neuroinflammation. Lionheart Health's multi-modality platform—including BodStim™, Brain Band™, and other patented bioelectric stimulation technologies—aligns closely with Dr. Maroon's life-long focus on neuroprotection, inflammation reduction, and performance longevity. Howard Leonhardt, Founder and Executive Chairman of Lionheart Health, Inc., stated that Dr. Maroon's work bridging neuroscience, inflammation control, and longevity science aligns perfectly with the company's mission to increase healthspan through measurable improvements in muscle, brain, and immune function.

Lionheart Health is currently advancing multiple clinical initiatives focused on improving functional biomarkers of aging, including grip strength, gait speed, cognition, memory, inflammatory markers, and regenerative protein expression. Dr. Maroon will advise on brain health clinical study design, neurocognitive endpoint validation, concussion and neuroinflammation applications, and the translation of regenerative signaling science into clinical protocols. He commented that optimizing brain health is central to extending meaningful healthspan and looks forward to supporting Lionheart Health's efforts to scientifically validate innovative bioelectric therapies that aim to improve neurological resilience, reduce inflammation, and enhance overall vitality.

Lionheart Health's expanding intellectual property portfolio includes patents and patent-pending technologies targeting key regenerative and neuroprotective signaling pathways, including Klotho, Brain-Derived Neurotrophic Factor (BDNF), GDF10, SDF-1, PDGF, and eNOS. These pathways are recognized for their roles in neuroplasticity, synaptic resilience, angiogenesis, stem cell homing, endothelial health, and inflammation modulation. Through its patented bioelectric stimulation platforms, including Brain Band™ and BodStim™, Lionheart Health aims to modulate these regenerative protein expressions to support cognitive performance, memory retention, mood stability, and neurovascular integrity.

Brain health represents one of the three core pillars in which Lionheart Health is competing in the Semi-Finals of the $101M XPRIZE Healthspan Competition. The company's Brain Band™ was recently awarded a prestigious UCI Capstone Grant, providing a multidisciplinary team of five University of California, Irvine engineering PhD-level researchers who worked over a seven-month period to advance device optimization and signal validation. Lionheart Health has completed successful pre-clinical studies at AccuLab Life Sciences in San Diego with grant and credit line support, as well as a successful pilot clinical study in Brazil, further strengthening the scientific foundation of its neuro-regenerative platform. The company is preparing to enroll soon in a combination BodStim™ bioelectric stimulation exercise suit and Brain Band™ clinical trial for brain health.

Dr. Maroon brings more than four decades of leadership in academic neurosurgery, clinical innovation, and performance medicine. He has performed thousands of complex brain and spine procedures and is internationally recognized for advancing minimally invasive neurosurgical techniques. Throughout his tenure at UPMC, he has helped shape modern standards in concussion management, traumatic brain injury care, and sports-related neurological safety. In addition to his clinical accomplishments, Dr. Maroon is a prolific scientific author with more than 300 peer-reviewed publications and multiple textbooks in neurosurgery, inflammation science, and sports medicine. His research has contributed to deeper understanding of neuroinflammation, omega-3 fatty acids in brain protection, performance longevity, and integrative strategies for preserving cognitive function across the lifespan.

Source Statement

This news article relied primarily on a press release disributed by Newsworthy.ai. You can read the source press release here,

blockchain registration record for the source press release.
;